From what's tradeable today to what's realistically coming. Bigger = more selling pressure ahead.
The dominant, actionable mechanism is 960,000 pre-funded warrants at $0.0001 held by Armistice Capital, resale-registered and effective as of 2026-07-20, cashless-exercisable with only a 9.99% blocker gating the pace. That is 38% of the ~2.55M tradeable float in supply that requires zero further company action and no capital outlay to reach the tape — the functional equivalent of a fully paid, registered secondary sitting on the bid. Add 62,400 PA warrants at $3.9063 and the entirety of the C/B warrant stack ($3.00 and $4.50 strikes) sitting out of the money against a $2.09 print, plus an ATM that reopens 60 days after the July effectiveness. Offsetting factors that hold this off a 9-10: there are NO convertible notes, NO preferred outstanding, and NO variable-rate or reset mechanics anywhere in the structure (the PIPE expressly bars variable-rate transactions for one year), so the OTM warrants cannot ratchet down into the money. Issuance cadence has nonetheless been relentless — ATM drip, December 2025 registered direct, April 2026 inducement, July 2026 PIPE — with shares outstanding up 14.4% in the six weeks from 2026-03-27 to 2026-05-06 alone.
Share Structure
Float to Fully Diluted Breakdown
Reported float from Insight Sentry (NASDAQ:CVKD), as-of date unknown. Adjusted based on SEC filing analysis.
Reported float + filing adjustments
MEDIUM confidence
Registered and convertible shares that could enter the float relative to current float size.
Share estimates are approximate. Convertible share counts based on current price. Review SEC filings for exact terms.
See the full breakdown
Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.
Sign in to continue- 1-for-15·Aug 20, 2024~2 yr ago
- ▸960,000 pre-funded warrants at $0.0001, resale-registered effective 2026-07-20, cashless-exercisable, 9.99% blocker — functionally free-trading stock
- ▸1,920,000 Series C-1/C-2 warrants at $3.00 (C-2 immediately exercisable; C-1 requires stockholder approval)
- ▸1,142,860 Series B-1/B-2 warrants at $4.50, registered and exercisable
- ▸ATM facility with H.C. Wainwright (3.0% commission) — resumes 60 days after the 2026-07-20 effective date
- ▸414,748 December 2025 investor warrants at $10.60
- ▸403,000 options plus 264,587 shares available under the 2022 Plan, with a 20%-of-outstanding annual evergreen
- ▸Repeat warrant-inducement mechanic: strikes repriced downward twice ($26.25 to $16.50 to $4.50), each time generating a fresh double tranche of new warrants
Market Data
$2.04
$6.32M
3.10M
2.64M
89.7K